期刊
NANOMEDICINE
卷 17, 期 3, 页码 167-179出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2021-0229
关键词
cancer; colloid; colon adenocarcinoma; drug delivery; murumuru butter
资金
- FAP-DF/Brazil [0193.001020/2015, 0193.001626/2017]
- PRONEX FAP-DF
- CNPq [0447628/2014-3, 193.001.200/2016]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Brasil (FAPESP) [2019/10261-2]
This study successfully developed a new curcumin carrier called SLN-Cs consisting of murumuru butter nanoparticles, and demonstrated that SLN-Cs were more toxic to colon adenocarcinoma cells, indicating that SLN-Cs are suitable carriers of curcumin in aqueous media.
Aim: To develop a new curcumin carrier consisting of murumuru butter nanoparticles (SLN-Cs). Methods: A phase-inversion temperature method was used to produce SLN-Cs. The interaction of SLN-Cs with murine colon adenocarcinoma (CT26) cells in vitro was analyzed by confocal microscopy. Results: Stable SLN-Cs with a high curcumin-loading capacity were obtained. The SLN-Cs were more toxic to CT26 than free curcumin. Fluorescence microscopy images showed the SLN-Cs to be taken up by CT26 cells in vitro. Conclusion: These results indicate that SLN-Cs are suitable carriers of curcumin in aqueous media.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据